Johns Hopkins Medicine laboratory scientists say they have developed a potential new way to treat a variety of rare genetic diseases marked by too low levels of specific cellular proteins.
Phase 3 AURORA trial of Descartes-08 in myasthenia gravis on track to commence in 1H25; Deep and durable responses maintained over 12 months in ...
Five years after the pandemic began, many local health officials say that the politicization of Covid has left them with ...
A single molecular switch is essential for blood stem cells to enter an activated, regenerative state in which they produce new blood cells, according ...
With grant funding from governments at multiple levels in Canada, Entos Pharmaceuticals is looking to plant roots at a CAD $198.5 million ($137.2 million) R&D and manufacturing hub in Edmonton. | The ...
In this article, we will look at the 10 Best Growth Stocks to Invest in for the Next 10 Years. On March 8, Ben Snider, ...
The National Institutes of Health is terminating dozens of studies examining why people are hesitant about vaccines and how ...
University at Albany researchers at the RNA Institute are pioneering new methods for designing and assembling DNA ...
Sunburns and aging skin are obvious effects of exposure to harmful UV rays, tobacco smoke and other carcinogens. But the ...
Assembling DNA nanostructures at more moderate temperatures opens up the possibility of using the structures in biomedical applications.
Pancreatic cancer’s deadly resilience may be tied to extrachromosomal DNA, which allows tumor cells to rapidly adapt to ...
Science never ceases to amaze us, and one of the most mind-blowing facts about the human body is the sheer length of our DNA.